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ParahippocampusPain is a multidimensional phenomenon. Patients with somatoform pain disorder suffer from long-lasting
pain, with the pathology being closely associated with cognitive–emotional components. Differences be-
tween these patients and controls in cerebral responses to pain stimuli have been reported. However, to
our knowledge, no studies of somatoform pain disorder have evaluated altered pain-related brain activation
as modulated by emotional dysregulation. We examined the distinct neural mechanism that is engaged in re-
sponse to two different pain intensities in a sad emotional condition, performing functional magnetic reso-
nance imaging (fMRI) on a group of 11 somatoform pain patients and an age-matched control group. Our
results showed that the ratio for low-pain intensity ratings between the sad and neutral conditions in pa-
tients was higher than in controls. They also showed signiﬁcant increased activation in the anterior/posterior
insula in the low pain sadness condition. Furthermore, there was speciﬁc functional connectivity between the
anterior insula and the parahippocampus in patients during presentation of low-pain stimuli in the sad con-
text. These ﬁndings suggest that a negative emotional context such as sadness contributes to dysfunctional
pain processing in somatoform pain disorder. Greater sensitivity to low levels of pain in an emotional context
of sadness might be an important aspect of the psychopathology of somatoform pain disorder.
© 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.1. Introduction
Pain hasmanyphysiological aswell as psychological aspects. Clinical
and experimental studies have elucidated the sensory-discriminative
and the emotional–affective dimensions of pain (Price, 2002), and
have revealed that both dimensions are inﬂuenced by various emotion-
al elements aroused by psychological stimuli, including such states as
fear, anxiety, and sadness. For example, greater subjective pain intensi-
ties have been reported during a state of sadness (Lehoux and Abbott,
2011; Loggia et al., 2008). Various studies have explored brain mecha-
nisms underlying emotional modulation of pain in healthy subjects
(Apkarian et al., 2005; Berna et al., 2010; Peyron et al., 2000). We
have used functionalmagnetic resonance imaging (fMRI) andmagneto-
encephalography (MEG) to show that sadness can enhance subjective
pain perception and pain-related brain activity, including that of thef Psychiatry andNeurosciences,
rsity, 1-2-3 Kasumi, Minami-ku,
81 82 257 5209.
ino).
Inc.Open access under CC BY-NC-ND lanterior cingulate cortex (ACC), during pain processing in healthy vol-
unteers (Yoshino et al., 2010; Yoshino et al., 2012).
Somatoform pain disorder is deﬁned as the occurrence of one or
more physical complaints for which appropriate medical evaluation
reveals no explanatory physical pathology or pathophysiologic mech-
anism, or when such a pathology is present, the physical complaints
or resulting impairment are grossly in excess of what would be
expected from the physical ﬁndings, according to the Diagnostic and
Statistical Manual of Mental Disorders IV (DSM-IV) (APA, 1994).
This disorder diminishes quality of life and is associated with in-
creased depression and anxiety (Williams et al., 2012). Various stud-
ies have examined the mechanisms underlying chronic pain states
from the brain structural, neuroplastic, neurochemical, electrophysio-
logical, hormonal, and cognitive–emotional abnormality viewpoints
(Apkarian et al., 2005; de Greck et al., 2011; Fayed et al., 2012; May,
2008; McEwen and Kalia, 2010; Noll-Hussong et al., 2013; Otti et al.,
2013; Seifert and Maihöfner, 2011). fMRI studies of somatoform
pain disorder patients report differences between patients and con-
trols in cerebral responses to pain stimuli (Gündel et al., 2008;
Stoeter et al., 2007). For example, Gündel et al. (2008) investigated
cerebral processing of noxious heat stimuli, and found pain-related
hypoactivation of the ventromedial prefrontal/orbitofrontal cortex,
along with hyperactivation of the parahippocampus, amygdala and
anterior insula in the patient group. Stoeter et al. (2007) investigatedicense.
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er activation of brain regions such as the thalamus, anterior insula,
hippocampus, and prefrontal cortex in the patient group.
Emotion plays an important modulatory role in pain perception of
somatoform pain disorder patients (Dimsdale and Dantzer, 2007),
and it is well established that negative emotions increase pain sensi-
tivity in patients with chronic pain disorders as compared to controls
(Burns, 2006; Zautra et al., 2005). However, to our knowledge, there
are no other fMRI studies on negative emotion-induced brain activity
changes in response to pain stimuli in somatoform pain disorder. Pain
sensitivity in such patients is signiﬁcantly affected by negative emo-
tion (Burns, 2006; Zautra et al., 2005), and elucidating the mecha-
nisms underlying this relationship is of both theoretical and clinical
importance. Our previous studies examined sadness in this context
(Yoshino et al., 2010, 2012). Sadness is one of the basic human emo-
tions and it is generally accepted that sadness occurs in response to
an aversive experience (Ellsworth and Smith, 1988).
We used fMRI to investigate how sadness affects subjective pain and
associated brain mechanisms in patients with somatoform pain disor-
der, who responded to both moderate and low pain intensities. We hy-
pothesized that both subjective pain intensities and pain-related brain
activations (as modulated by sadness) would be greater in patients
with somatoform pain disorder as compared to healthy subjects.
Considering the relationship between somatoform pain disorder
and cognitive–emotional abnormalities, the expected altered brain
processing should involve mainly the brain structures mediating the




The participants were eleven patients with somatoform pain disor-
ders (6 women, mean age = 40.9 ± 6.5 years), diagnosed according
to the DSM-IV criteria, and eleven gender- and age-matched control
subjects (6 women, mean age = 40.6 ± 6.1 years). All participants
were right-handed Japanese. Patients were recruited from outpatient
sources at theHiroshimaUniversity Hospital. The Structured Clinical In-
terview for DSM-IV (SCID) (Spitzer et al., 1992) was used to conﬁrm
participants' diagnostic status. Any analgesic that would be expected
to alter pain perception was discontinued 24 h prior to fMRI scanning.
Control participants were recruited from non-clinical populations and
werematched to patients according to age and gender. The control par-
ticipants endorsed no chronic pain problems and had no history of psy-
chiatric disorders. All participants gave their written informed consent
before participation, according to a protocol approved by the ethics
committee of Hiroshima University.
2.2. Clinical assessments
2.2.1. Pain characteristics
The Short-Form McGill Pain Questionnaire (SF-MPQ) was used to
assess pain characteristics (Melzack, 1987). The SF-MPQ consists of 15
descriptors (11 sensory, 4 affective) which are rated on an intensity
scale as follows: 0 = none, 1 = mild, 2 = moderate or 3 = severe.
The SF-MPQ is based on the full-length version and has a high degree
of internal consistency. The SF-MPQ also includes the Present Pain
Intensity (PPI) index and a visual analog scale (VAS). The Pain
Catastrophizing Scale (PCS) was also used (Sullivan et al., 1995). The
PCS is a 13-item self-report inventory designed to assess the extent to
which a person uses a catastrophic thinking approach in response to
pain stimuli. Patients are instructed to reﬂect on a painful experience
and to indicate the extent to which they thought about each statement
using a 5-point Likert scale ranging from 0 (“not at all”) to 4 (“all the
time”). Total catastrophizing scores range from 0 to 52. The PCS hasdemonstrated high internal consistency (Cronbach's α = 0.91) and
high test-retest reliability over a 6-week period (r = 0.75).
2.2.2. Psychometric evaluation
The Beck Depression Inventory (BDI) was used to measure
depression symptoms (Beck et al., 1961). The BDI, a widely used
21-item self-report measure of depressive symptom severity, has ac-
ceptable psychometric properties that have been reviewed elsewhere
(Rabkin and Klein, 1987). The State-Trait-Anxiety Inventory (STAI)
was also administered (Spielberger, 1983). This inventory includes
two scales to differentiate anxiety related to a transitory or situational
state (STAI-S), and trait anxiety (STAI-T) that is a more consistently
stable characteristic of the individual, resembling a personality trait.
The Short Form Health Survey (SF-36) is a 36-item questionnaire
that assesses functional status and well-being. The SF-36 is comprised
of the Physical Component Summary (PCS) and the Mental Compo-
nent Summary (MCS). The PCS has four subscales: (1) physical func-
tioning, (2) role-physical factors in functioning, (3) bodily pain, and
(4) general health. The MCS has an additional four subscales:
(5) vitality, (6) social functioning, (7) role-emotional factors in func-
tioning and (8) mental health. Each scale score ranges from 0 to 100,
with 0 representing the poorest functioning and 100 representing op-
timal health. The Cronbach's alpha reliability estimates for the Japa-
nese SF-36 range from 0.71 to 0.87 for the subscales, indicating
good test–retest reliability (Fukuhara et al., 1998). The Japanese ver-
sion of the National Adult Reading Test (NART), a reading test of 50
irregularly spelled Japanese words, was used as an assessment of in-
tellectual functioning (Matsuoka et al., 2006; Nelson, 1982).
2.2.3. Experimental paradigm and stimuli
The experiment was a simple 2 × 2 block within-subject design
with the variables of pain stimulation (moderate or low) and emo-
tional context (sad or neutral). A schematic representation of the ex-
perimental design is shown in Fig. 1. Facial expressions were
presented for 4 s. The same emotion was represented four times se-
quentially via different randomly selected faces. Pain stimuli were de-
livered while the facial stimuli were presented. The interval between
the pain stimuli was randomized, with an average duration of 1 s be-
tween stimuli (0.8–1.2 s). The present experimental design was a
simpliﬁcation and modiﬁcation of the design used in our previous
studies (Yoshino et al., 2010, 2012). We used two emotional condi-
tions (sad or neutral) instead of three and a block design instead of
an event-related task design. Each block was composed of four facial
pictures with the same emotional valence (sad or neutral), sixteen
pain stimuli of the same intensity (moderate or low), a rating activity,
and a rest period. Each block was 32 or 36 s in duration. The partici-
pants rated the average intensity of the pain stimuli at the end of
each block using a Numerical Rating Scale (NRS) projected onto the
same screen for 8 s. The whole paradigm comprised a sequence of
16 randomized blocks (four blocks for each condition), and the total
experimental duration was about 9 min. The order of the experimen-
tal conditions was counterbalanced across participants to mitigate
order effects.
An intraepidermal stimulationmethod (Inui and Kakigi, 2012; Inui et
al., 2002)was used to induceminor pain at the superﬁcial skin level. The
original method was slightly modiﬁed to provide a higher selectivity for
the activation of nociceptors.Weused a stainless steel concentric bipolar
needle electrode (Nihon Kohden, Tokyo, Japan) for intraepidermal stim-
ulation. The anode was an outer ring 1.2 mm in diameter, and the cath-
ode was an inner needle that protruded 0.1 mm from the outer ring.
This needle electrode permitted the selective stimulation of cutaneous
A-delta ﬁbers. The electrical stimuli used were 50 Hz current constant
double pulses of 0.5 ms in duration. The electrical stimuli were intended
to evoke the feeling of receiving an injection. The needle electrode
was exchanged for each participant. The constant current stimulator
(SEN-2201; Nihon Kohden, Tokyo, Japan) was located outside the MRI
Fig. 1. Schematic representation of the experimental design. Facial expressions were presented for 4 s. The same emotion was represented 4 times sequentially in different faces
randomly selected. Pain stimuli were delivered while the facial stimuli were presented. The interval between the pain stimuli was randomized, with an average of 1 s. Immediately
after the pain stimuli, participants were instructed to rate their average level of pain across the 8 s using a numeric rating scale (NRS) ranging from 0 (no pain at all) to 10 (worst
imaginable pain). They pushed the button to stop the bar moving between 0 and 10 to rate the intensity of their pain perception.
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compatible extension cable. We established the stimulus current inten-
sities for moderate pain (1.3 mA) and low pain (0.35 mA) based on our
previous studies (Yoshino et al., 2010, 2012) and a preliminary experi-
ment conducted before the present study. We stimulated the left fore-
arm of each participant. The insertion of the needle electrode caused
no bleeding or visible damage to the skin of any participant.
We used pictures of faces as emotional stimuli of the type that have
been employed in previous functional neuroimaging studies that exam-
ined neural responses to emotional stimuli (Doallo et al., 2012;
Groenewold et al., 2012; Whalen et al., 2013). We used sad and neutral
facial expressions to induce different emotional contexts while the par-
ticipants were exposed to the pain-inducing stimuli. Eight sad or eight
neutral facial expressions displayed by eight different Japanese individ-
uals (4 females and 4 males) were taken from a standardized series of
stimuli (Kamachi et al., 2001) andwere presented for 4 s each per facial
image. During fMRI recording, participants were instructed to imagine
how the person depicted in each image felt when the image appeared
on the screen. An MR-compatible back projection screen (Silent Vision
SV-6011; Avotec, USA) was used to present the facial stimuli.
2.2.4. Behavioral data analysis
Subjective pain intensity ratingswere analyzed using 3-way repeated
measures ANOVAs performed using SPSS version 16.0, with group (pa-
tients or controls) as a between-subjects factor, and pain (moderate or
low) and emotional context (sad or neutral) as within-subjects factors.
We examined the pain intensity rating ratios between the sad and neu-
tral contexts in order to contrast the strength of pain perception in the
sad emotional context condition with the neutral condition, based on a
previous study (Murray and Arnott, 1993). The ratio was analyzed
using 2-way repeated measures ANOVAs, with group (patients or
controls) as a between-subjects factor and pain (moderate or low) as a
within-subjects factor. These data were also examined using post-hoc
tests performed using SPSS version 16.0.
2.2.5. fMRI acquisition
The fMRI procedure was performed using a Magnex Eclipse 1.5 T
Power Drive 250 (Siemens, Munich, Germany). A time course series of
366 scans was acquired using T2*-weighted, gradient echo, echo planarimaging (EPI) sequences. Each volume consisted of 28 slices,with a slice
thickness of 4 mmwith no gap, and covered the entire cerebral and cer-
ebellar cortices. The time interval between two successive acquisitions
of the same image (TR) was 3000 ms, the echo time (TE) was 46 ms,
and the ﬂip angle was 90°. The ﬁeld of view (FOV) was 256 mm, and
the matrix size was 64 × 64, giving voxel dimensions of 4 mm ×
4 mm × 4 mm. Scan acquisition was synchronized to the onset of
each trial. After functional scanning, structural scans were acquired
using a T1-weighted gradient echo pulse sequence (TR =2160 ms;
TE = 3.93 ms; ﬂip angle = 15°; FOV = 256 mm; voxel dimensions
of 1 mm × 1 mm × 1 mm) to facilitate localization.2.2.6. fMRI analysis
Image processing and statistical analyses were carried out using
Statistical Parametric Mapping (SPM8) software (Wellcome Depart-
ment of Cognitive Neurology, London, UK). The ﬁrst three volumes
of each fMRI run were discarded because the MRI signal was un-
steady. Each set of functional volumes was realigned to the ﬁrst vol-
ume. A slice timing correction was performed on the model slice to
correct for the sequential sampling of the brain in the slice direction.
Volumes were spatially normalized to a standard template based
upon the Montreal Neurological Institute (MNI) reference brain, and
ﬁnally smoothed using an 8-mm FWHM Gaussian kernel.
For the statistical analysis, subject-speciﬁc t-contrast images were
calculated for the pain effects using the general linear model (ﬁrst
level analysis). For each participant the preprocessed data were
assigned to the following four conditions in the model speciﬁcation:
High pain during sad facial images, low pain during sad facial images,
high pain during neutral facial images, and low pain during neutral
facial images. These contrasts were entered into the second level
analysis. Using group analysis according to a random effects model,
we conducted repeated measures 3-way ANOVAs as implemented
in SPM8 with group (patients or controls) as a between-subjects fac-
tor and pain (moderate or low) and emotional context (sad or neu-
tral) as within-subjects factors. BDI, STAI-S, and STAI-T scores were
used as covariates to control for individual differences in depressive
and anxiety states, in consideration of the modulatory effects of de-
pression and anxiety on pain sensitivity. The spatial coordinates pro-
vided by SPM8, which are in MNI brain space, were converted to
Table 1







Age 40.9 ± 6.5 40.6 ± 6.1 0.1ns
Female/male 6/5 6/5 0.0ns
Pain duration (months) 91.0 ± 85.7 – –
Rating of clinical pain (NRS) 7.6 ± 1.7/10 – –
Psychiatric diagnosis
Pain disorder 11/11 – –
Current major depressive episode 0/11 – –
Major depression in history 5/11 – –
Generalized anxiety disorder 3/11 – –
Other psychiatric disorders 0/11 – –
[Psychometric variables]
BDI 15.9 ± 11.1 4.0 ± 4.9 3.2⁎⁎
STAI
State 55.3 ± 11.3 37.8 ± 8.6 4.1⁎⁎
Trait 55.8 ± 11.9 41.4 ± 10.7 3.0⁎⁎
SF-36
Physical functioning 84.5 ± 13.7 97.3 ± 3.4 −3.0⁎
Role physical 45.5 ± 48.5 84.1 ± 23.1 −2.4⁎
Bodily pain 39.5 ± 28.0 92.7 ± 13.4 −5.7⁎⁎⁎
General health 33.7 ± 23.9 75.2 ± 14.9 −4.9⁎⁎⁎
Vitality 38.2 ± 28.6 59.5 ± 12.7 −2.3⁎
Social functioning 63.6 ± 21.3 94.3 ± 11.7 −4.2⁎⁎⁎
Role emotional 54.5 ± 45.4 81.8 ± 34.6 −1.6 ns
Mental health 35.3 ± 20.1 52.0 ± 10.3 −2.5⁎
NART 110.1 ± 6.7 112.9 ± 4.3 −1.2 ns
SF-MPQ
Sensory 12.5 ± 8.2 – –
Affective 3.3 ± 2.5 – –
PCS 35.5 ± 9.1 – –
ns = not signiﬁcant.
NRS = numeric rating scale; BDI = Beck Depression Inventory; STAI = State-Trait
Anxiety Inventory; SF-36 = Short Form-36; NART = National Adult Reading Test;
SF-MPQ = Short Form of the McGill Pain Questionnaire; PCS = Pain Catastrophizing
Scale.
⁎ Ptwo-sided b 0.05 (two sample t-test).
⁎⁎ Ptwo-sided b 0.01 (two sample t-test).
⁎⁎⁎ Ptwo-sided b 0.001 (two sample t-test).
Table 2
Patients' characteristics.
No Medical diagnosis Medications
1 Somatoform pain disorder Tryptanol 75 mg, sulpiride 150 mg,
loxoprofen 180 mgGeneralized anxiety disorder
Major depression in history
2 Somatoform pain disorder Tryptanol 75 mg, clonazepam 1.5 mg
Major depression in history
3 Somatoform pain disorder Mirtazapine 45 mg, pregabalin 75 mg,
loxoprofen 180 mg, eperison 100 mg
4 Somatoform pain disorder Nortriptyline 50 mg, clonazepam 0.5 mg,
tizanidine 3 mg
5 Somatoform pain disorder Tryptanol 75 mg
6 Somatoform pain disorder Duloxetine 40 mg, tizanidine 3 mg
7 Somatoform pain disorder Amoxapine 25 mg
8 Somatoform pain disorder Tryptanol 25 mg, trazodone 25 mg
Major depression in history Loxoprofen 180 mg
9 Somatoform pain disorder Duloxetine 20 mg, quetiapine 25 mg,
clonazepam 0.5 mg, sodium valproate 400 mgGeneralized anxiety disorder
10 Somatoform pain disorder Nortriptyline 150 mg, tizanidine 3 mg
Generalized anxiety disorder
Major depression in history
11 Somatoform pain disorder Tryptanol 50 mg, trazodone 50 mg,
carbamazepine 200 mg, clonazepam 1 mg,
eletriptan 20 mg
Major depression in history
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using the MarsBar SPM Toolbox. Peak voxel parameter estimates from
interactions were examined using post-hoc Bonferroni multiple com-
parisons performed in SPSS version 16.0.
We conducted a psychophysiological interaction (PPI) analysis
(Friston et al., 1997) to examine interactions between brain regions
in relation to the experimental paradigm. This approach can capture
the way in which activity in one brain regionmodulates activity in an-
other region by speciﬁcally assessing responses to the active task rel-
ative to an informative baseline. To undertake PPI analysis a design
matrix is established, which typically contains three columns of vari-
ables as follows: (1) a psychological variable that reﬂects the experi-
mental paradigm, (2) a time series variable representing the time
course of the source region; here, the source region was a 6-mm
sphere with a center deﬁned by the peak coordinate of the foregoing
analysis, and (3) a variable that represents the interaction between
(1) and (2). The regression coefﬁcient for the interaction term pro-
vides a measure of PPI. In the present context, a signiﬁcant effect for
PPI means that the correlation (or covariance) between the source
and the sink region during an emotional pain condition is signiﬁcantly
different from that during another emotional condition. In this regard,
PPI analysis assesses differences in functional connectivity between
the regions of interest. To perform PPI analyses, the ﬁrst eigenvariate
time series of the 6-mm sphere activated according to the previous
analyses was extracted. The effect of the interaction term was then
studied using the contrast [1 0 0], where the ﬁrst column represents
the interaction term. The extracted individual images were then
taken to the second level to perform a random effects analysis, using
a one-sample t-test.
The statistical threshold for all the imaging analyses described
above was set at an uncorrected p value of 0.001 and at a minimum
cluster size of 20 voxels, based on previous pain related fMRI studies
(Ochsner et al., 2006; Yoshino et al., 2010).
Finally, we examined the correlations between the brain regions
involved in modulating low pain levels within the context of sadness
and the sadness-speciﬁc low-pain rating scores of patients. We also
analyzed the correlations between the brain regions involved in mod-
ulating low pain levels within the context of sadness and BDI or STAI
scores for all participants, and examined whether sadness-induced
pain perception changes were correlated with individual differences
in depressed mood or anxiety state. A correlation analysis was
performed for the brain areas for which there was a signiﬁcant inter-
action effect in the 3-way ANOVAs (the anterior/posterior insula and
the hippocampus) as regions of interest (ROIs).
3. Results
3.1. Participant characteristics
Detailed demographic and clinical characteristics of the participants
are presented in Tables 1 and 2. The clinical pain in the patient group
was located in the head (n = 4), mouth (n = 4), chest (n = 2), or
abdomen (n = 1). Patients felt more depressive and anxious prior to
the study than did controls and reported more impairment in their
daily activities. No signiﬁcant differences in NART performance (intelli-
gence levels) between the groups were observed.
3.2. Behavioral results
Participants reported different pain intensities across the emo-
tional context conditions (Table 3). A 3-way ANOVA revealed a signif-
icant main effect of emotional context, F (1, 20) = 7.69, p b 0.05;
pain intensities in the sad emotional context condition were signiﬁ-
cantly higher than in the neutral condition. No signiﬁcant differences
in subjective pain perception between the groups were observed.Regarding the ratio for pain intensity ratings between the sad and
neutral conditions, a 2-way ANOVA revealed a signiﬁcant interaction
between group and pain, F (1, 20) = 4.96, p b 0.05. Bonferroni post-
hoc tests showed that the ratio for low pain levels between the sad
786 A. Yoshino et al. / NeuroImage: Clinical 2 (2013) 782–789and neutral conditions in patients was higher than the ratio for moder-
ate pain levels in patients and for low pain levels in controls (p b 0.05).
3.3. fMRI data
3.3.1. Brain regions involved in pain perception (main effect of ‘pain’)
Signiﬁcant changes in signal intensity were detected in a number of
brain regions related to pain perception (Table 4), including the ACC,
insula, thalamus, second somatosensory area (SII), and prefrontal cortex.
3.3.2. Differences in cerebral pain processing between groups
(interaction of ‘group’ × ‘pain’ × ‘emotion’)
To test differences in pain-related activation between patients and
controls during presentation of pain stimuli, we looked at brain acti-
vation as reﬂected in the interaction of ‘group’ × ‘pain’ × ‘emotion’
(Fig. 2A–C). There was signiﬁcant activation in the anterior insula,
posterior insula, and hippocampus.
3.4. Post-hoc comparisons between groups
3.4.1. Anterior insula
Activation during the low pain sad and high pain neutral conditions
was signiﬁcantly greater in patients than in controls (p b 0.05). Activa-
tion during the lowpain in neutral conditionwas signiﬁcantly greater in
controls than in patients (p b 0.05).
3.4.2. Posterior insula
Activation during the low pain sad condition was signiﬁcantly
greater in patients than in controls (p b 0.01). Activation during the
low pain neutral condition was signiﬁcantly greater in controls than
in patients (p b 0.01).
3.4.3. Hippocampus
Activation during the high pain neutral condition was signiﬁcantly
greater in patients than in controls (p b 0.01). Activation during the
low pain neutral condition was signiﬁcantly greater in controls than
in patients (p b 0.001).
3.5. Psychophysiological interaction (PPI) analysis
The above whole-brain ANOVAs revealed that blood oxygenation
level-dependent (BOLD) responses for the anterior/posterior insula
during the presentation of low-pain stimuli were larger for the sad
condition than for the neutral condition in patients. PPI analyses
were performed to assess possible functional connectivity differences
between patients and controls in the anterior insula [6-mm sphere
centered x = 28, y = 22, z = −16], with other areas focusingTable 3
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*Statistically signiﬁcant difference between emotions (p b 0.05).
♦Signiﬁcant interaction between group and emotion (p b 0.05). Bonferroni's post hoc
tests showed that the ratio between sad and neutral on low pain in patients was
more highly rated than moderate pain in patients and low pain in controls (p b 0.05).primarily on the low pain sad emotional context condition, given
that many studies suggest that the anterior insula is associated with
the affective dimension of pain (Craig, 2002; Gu et al., 2013; Yuan
et al., 2013). Considering behavioral and fMRI data results, we exam-
ined brain region connectivity for the low pain sadness condition.
The PPI analysis for the sad-speciﬁc low pain component ((low
pain with sad facial images) − (low pain with neutral facial images))
revealed that anterior insula activity was accompanied by increased
functional interaction with the right parahippocampus [x = 24,
y = −10, z = −26; z-score 4.28, cluster extent 30] (Fig. 2D), to a
greater extent in patients than in controls.
3.6. Correlation analysis
Sadness-speciﬁc lower pain level rating scores were positively
correlated with sadness-speciﬁc activation during low-pain stimuli
in the anterior insula (r = 0.71, p = 0.019). This ﬁnding emerged
in the patient group. No regions showed negative correlations with
pain rating scores.
No ROIs showed positive or negative correlations between sadness-
speciﬁc activation during low-pain stimuli and BDI or STAI scores.
4. Discussion
In comparison to the matched controls, we demonstrated that the
ratio for low-pain intensity ratings between the sad and neutral con-
ditions in patients was higher than in controls. At the same time, the
patients also showed stronger anterior/posterior insula activation
induced by sadness-context low-pain stimuli. In patients, we found
more effective connections between the parahippocampus and ante-
rior insula during the presentation of low-pain stimuli in the sad con-
text. This is the ﬁrst fMRI study that has compared somatoform pain
disorder patients with controls, in order to examine the relationship
between pain perception and sad emotional context.
4.1. Subjective pain intensities
We examined changes in perceived pain intensity as inﬂuenced by
sadness, using the same stimuli across sad andneutral conditions. Subjec-
tive pain intensities in the sad context were signiﬁcantly greater than the
subjective pain intensities in the neutral context, for both patient and
control groups. The ﬁnding that sadness subjectively increased pain rep-
licates the ﬁndings of our previous studies (Yoshino et al., 2010, 2012).
However, we did not ﬁnd signiﬁcant differences in pain threshold be-
tween the groups. A behavioral study also reported this pain-amplifying
effect for sadness both in participants with and without chronic pain,
but there was no difference between the groups (van Middendorp et
al., 2010). No between group differences in terms of physical pain stimu-
lus intensity have been reported acrossmanyother fMRI studies (Baliki et
al., 2006; Gündel et al., 2008; Kirsch et al., 2005; Stoeter et al., 2007).
In the present study, there was a signiﬁcant difference between
groups in the ratio between sad and neutral contexts for low-pain
stimuli. Previous studies have identiﬁed greater pain responses asso-
ciated with negative emotions in patients with chronic pain disorder
than among controls (Burns, 2006; Zautra et al., 2005). Furthermore,
it has also been reported that low-pain stimuli are experienced as
more aversive by these patients (Morris et al., 1995). Our results sug-
gest that patients with somatoform pain disorder may be more sus-
ceptible to the perception of low-pain stimuli in a sad emotional
context, as compared to a neutral context.
4.2. Insula
Insula activation has been observed during a majority of imaging
studies involving pain stimuli (Apkarian et al., 2005). Various studies
have demonstrated that negative emotional states enhance pain-
Fig. 2. BOLD-signal differences between patients with somatoform pain disorder and controls. A–C; Group × pain × emotion interactions in the insula and the hippocampus are
shown (3-way-ANOVA; BDI, STAI-S, and STAI-T scores as covariates). In patients, stronger activations were found in the moderate pain neutral and low pain sad conditions. In con-
trols, stronger activation was found in the moderate pain sad condition. D; The graph shows the parameter estimate of the peak coordinate as the difference of connectivity strength
for low-pain stimuli in the sad condition. Anterior insula activity covaried more strongly with activity in the parahippocampus in patients.
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The present study found that activation of the anterior/posterior insula
during low-pain stimuli in a sad emotional context was stronger in
somatoform pain disorder patients than in controls. Previous studies
also reported stronger activation of the insula for pain stimuli in patients
with somatoform pain disorder as compared to controls (Gündel et al.,
2008; Stoeter et al., 2007). We suggest that a vulnerability to pain per-
ception modulated by emotional dysregulation, as well as pain percep-
tion itself, is one of the important pathophysiological factors underlying
somatoform pain disorder.Peyron et al. (2000) found that insula activation is positively cor-
related with pain ratings. The present study also found that anterior
insula activation associated with sad-context low-pain stimuli is re-
lated to subjective ratings of such stimuli provided by patients. We
suggest that the anterior insula activations we observed reﬂected
the subjective pain ratings that we obtained.
These ﬁndings suggest the possibility that sadness is associated
with more increased sensitivity to pain perception in patients with
somatoform pain disorder as compared to controls, and that the
insula is involved in this process.
Table 4
Main effect of pain.
Brain regions L/R x/y/z z-score Cluster extent
ACC (BA 32) R 8/34/24 3.32 43
ACC (BA 24) R 6/20/30 3.75 124
ACC (BA 24) L −8/6/32 4.17 152
Insula R 42/0/−4 3.40 24
Insula L −40/−8/−6 4.22 50
Thalamus R 6/−4/12 4.07 227
Thalamus L −8/−4/14 5.21 259
Superior frontal gyrus
(BA9) L −18/54/26 3.96 65
Middle frontal gyrus
(BA8) L −34/24/48 4.58 118
Inferior frontal gyrus
(BA45) L −56/8/8 5.63 392
Caudate L −16/14/8 3.69 21
S1 (BA2) L −66/−24/34 4.12 78
S2 (BA40) R 60/−24/20 5.82 468
S2 (BA40) L −60/−24/20 4.94 347
SMA (BA6) L −2/12/58 5.72 435
M1 (BA4) R 50/2/44 3.99 114
M1 (BA4) L −38/−8/62 4.23 65
Middle temporal gyrus L −56/−62/6 3.99 58
Superior temporal gyrus L −56/4/10 5.63 81
Brain regions stated inMNI coordinateswith activationmaxima of experimentally induced
p, thresholded at uncorrected p b 0.001. Minimum activation cluster size is 20 voxel.
ACC, anterior cingulate cortex; S1, primary somatosensory cortex; S2, secondary
somatosensory cortex; SMA, supplementary motor area; M1, primary motor cortex.
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Reports of pain-related responses in the hippocampus have been
contradictory, but various studies have reported that the hippocam-
pus is involved in the processing of pain stimuli (Apkarian et al.,
2005; Peyron et al., 2000). The hippocampus plays a critical role in
supporting the inﬂuence of context on memory encoding, storage, be-
havior, and the retrieval of pleasant or aversive stimuli (Rudy, 2009).
Some evidence suggests that hyperalgesia induced by negative emo-
tional states is associated with activation in the hippocampus
(Berna et al., 2010; Ploghaus et al., 2001). Patients with somatoform
pain disorder show altered hippocampal activation in response to
pain stimuli, in comparison with controls (Gündel et al., 2008;
Stoeter et al., 2007). Studies also indicate that the hippocampus is
connected with pain-related brain regions such as the insula, and
that hippocampus activity can enhance pain perception (Kong et al.,
2008; Ploghaus et al., 2001). The present study found strong hippo-
campus activation in patients for low pain stimuli in a sad emotional
context. We speculate that a similar mechanism may also underlie
sadness-induced pain perception.
We conducted a PPI analysis to examine brain regions in relation to
the insula during sadness-speciﬁc low-pain perception. Anterior
insula activity was accompanied by increased functional interaction
involving the parahippocampus, to a greater extent in patients than
in controls. The parahippocampus plays a central role in recollection,
sending information from the hippocampus to the association areas
(Diederen et al., 2010). Previous studies have demonstrated effective
connectivity between the parahippocampus and anterior insula in
healthy controls (Ploner et al., 2011; Tanaka et al., 2008). It has been
reported that stronger intensity of pain stimuli in a negative emotional
context is associated with neural activity in the anterior insula, medi-
ated by the parahippocampus (Ploner et al., 2011). Patients with
somatoform pain disorder show an altered activation pattern in the
parahippocampus in response to pain stimuli, in comparison to con-
trols (Gündel et al., 2008; Stoeter et al., 2007). We therefore assume
that an increased functional connectivity between the anterior insula
and parahippocampus may be a distinctive feature of somatoform
pain disorder in a sad emotional context. The present behavioral re-
sults suggest that the subjective experience of pain appears to be exac-
erbated by negative emotional states for such patients. They may
perceive even relatively low pain levels as more intense during sad-
ness, with conditioning possibly playing a role in this process. How-
ever, this interpretation may be premature, and further study is
needed to elucidate the relationship between pathophysiology in
somatoform pain disorder and the parahippocampus.
We also hypothesized that ACC activation would differ across pa-
tients with somatoform pain disorder and healthy controls. Although
there was a main effect of pain level on ACC activity, there were no
group differences, consistent with previous studies (Gündel et al.,
2008; Stoeter et al., 2007). Gündel et al. (2008) described a negative
correlation between intensity of patients' clinical pain and the experi-
mental pain stimuli in terms of ACC activation, and they have explained
this limited activation of the ACC in response to experimental pain in
terms of increased neuronal baseline activity due to the experience of
chronic pain. There is a clear need for continued research to elucidate
the role of the ACC in somatoform pain disorder.
The present study has several limitations. First, the small sample size
limits the robustness of our ﬁndings. Second, the display duration for
the facial images (4 s) was longer than that used in previous studies
(Doallo et al., 2012; Whalen et al., 2013). We must therefore consider
the possibility that any context-induced emotional effects might have
been attenuated via habituation. Third, a higher level of anxiety and de-
pression in patients may inﬂuence the fMRI data. Previous studies have
shown that somatoform patients have signiﬁcantly higher depression
or anxiety scores (Gündel et al., 2008; Stoeter et al., 2007).We analyzed
a 3-way ANOVA using BDI, STAI-S, and STAI-T scores as covariates, andadjusted the fMRI data accordingly. Furthermore, no brain regions
showed correlations between sadness-speciﬁc activation for low-pain
stimuli and BDI or STAI scores across the participants. These results
mean that the effects of depression and anxiety were probably limited
in the present study, but nevertheless we cannot rule out such effects.
Fourth, an uncertainty may remain in our experimental paradigm re-
garding the extent to which we adequately distinguished between
pain and emotion. It has been reported that pain itself is a speciﬁc emo-
tion (Craig, 2003), and pain and emotion showmuchoverlap in termsof
psychological and brain functional aspects although they are not neces-
sary the same. Finally, our exclusion criteria did not include all treat-
ments that might inﬂuence the patients' pain perception, such as
antidepressants, although it included opioids, and a 24 h analgesic-
free observation period prior to the fMRI was not generally fully effec-
tive. It has been reported that antidepressants have an analgesic effect
in somatoform pain disorder (Luo et al., 2009) and such drugs produce
clear changes in brain activity (Wiech and Tracey, 2009). We therefore
cannot rule out all treatment effects on the brain activity that we ob-
served in this study. However, it is not clear whether antidepressants
inﬂuence antinociceptive effects in acute pain (Schreiber et al., 2009).
Furthermore, any analgesic effects may be related to speciﬁc antide-
pressant effects (Luo et al., 2009). We believe that such treatment ef-
fects probably play a minor role in our ﬁndings, given that we
adjusted our fMRI data to control for the presence of depressive states
as described above.
In summary, our results provide evidence that patients with
somatoformpain disorder tend to show slightly higher pain sensitivities
to low pain stimuli in contexts of sadness. The insula, hippocampus, and
parahippocampus show altered activity under such conditions. These
results provide some insight into sadness-induced distinctive changes
in neural pain-related activity within the context of somatoform pain
disorder, with interactions between brain activity and emotional con-
text potentially playing an important role in the pathophysiology of
this disorder.
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